Menorrhagia

06/01/2001 - "The FibroPlant levonorgestrel IUS is effective in significantly reducing the amount of menstrual blood loss in women with menorrhagia. "
01/01/2013 - "The aim of the present study was to identify variables associated with treatment failure in women with menorrhagia who were treated with thermal balloon ablation (TBA) or levonorgestrel releasing intrauterine system (LNG-IUS), and to determine if there are subgroups where one treatment type is more effective than the other. "
01/01/2012 - "The levonorgestrel-releasing intrauterine system is an effective treatment for menorrhagia. "
06/01/2007 - "Use of levonorgestrel-releasing system provides both contraceptive and therapeutic effects in the treatment of menorrhagia."
01/01/2007 - "It has been shown that levonorgestrel-releasing intrauterine system (LNG-IUS) is an effective treatment of menorrhagia. "

05/01/1995 - "Tranexamic acid is a safe and effective form of medical therapy in women with menorrhagia and is highly likely to normalise blood loss in women losing 80 to 200 ml prior to treatment. "
01/01/2003 - "Nevertheless, tranexamic acid may be considered as a first-line treatment for the initial management of idiopathic menorrhagia, especially for patients in whom hormonal treatment is either not recommended or not wanted."
01/01/2003 - "In conclusion, the oral antifibrinolytic drug tranexamic acid is an effective and well tolerated treatment for idiopathic menorrhagia. "
10/01/2005 - "Tranexamic acid is a safe and effective form of medical therapy in women with menorrhagia; also increases quality of life in these women."
10/01/2005 - "To determine the efficacy of tranexamic acid in the treatment of idiopathic menorrhgia and to investigate the effect of medical treatment with tranexamic acid on the quality of life of the women with idiopathic menorrhagia. "

05/01/2001 - "When used for the treatment of menorrhagia, the efficacy of high-dose DDAVP intranasal spray (1.5 mg mL(-1)) was rated as 'excellent' after 655 (92%) of 721 daily uses. "
07/01/2005 - "Safety outcomes were not significantly greater in vWD patients with menorrhagia when OC were compared with intranasal DDAVP. "
05/01/1999 - "DDAVP is a useful treatment for menorrhagia and postnatally. "
07/01/1998 - "With the increasing availability of intranasal/subcutaneous DDAVP that could be readily administered at home for menorrhagia, there recently has been ongoing efforts internationally to determine the prevalence of vWD in females presenting with menorrhagia with a prevalence of 17% combined from two studies of 180 patients total. "
05/01/2008 - "Our results demonstrate a correlation between haemostatic parameters and menstrual flow following IN-DDAVP in women with menorrhagia and platelet dysfunction."

09/01/1990 - "A well controlled double blind prospective trial was undertaken to determine the efficacy of mefenamic acid in the treatment of menorrhagia. "
02/01/1983 - "Clinical trial of the efficacy of mefenamic acid in relief of menorrhagia and/or dysmenorrhoea."
11/01/1981 - "Efficacy of mefenamic acid in patients with a complaint of menorrhagia."
11/01/1981 - "Sixty-nine patients with a convincing history of menorrhagia completed a 4-cycle double-blind randomized placebo-controlled crossover trial of mefenamic acid taken during menstruation. "
05/01/1980 - "Studies in menorrhagia: (a) mefenamic acid, (b) endometrial prostaglandin concentrations."

02/01/2014 - "Eight female patients need oral contraceptives jointly to control menorrhagia. "
12/01/2013 - "A 10-year-old girl using oral contraceptives for menorrhagia presented with a decidual cast after discontinuing the drug. "
07/01/2012 - "Menorrhagia later in life can be managed by continuous oral contraceptives. "
09/01/2010 - "In adolescents with menorrhagia, testing for VWD before the initiation of oral contraceptives is cost-effective."
10/01/2002 - "In v. Willebrand-Jürgens-Syndrome oral contraceptives are favourable because it alleviates menorrhagia."

01/01/2013 - "Hormone releasing intrauterine system should be used more widely in primary care for menorrhagia, study concludes."
05/01/2011 - "Other treatments that can reduce symptoms include fibrinolytic inhibitors and hormones for menorrhagia."
05/01/2010 - "As a result, this may lead to decreased levels of circulating hormones, resulting in episodes of menorrhagia in the premenopausal population."
06/01/2008 - "Increase of the incidence of menstrual disorder as well as that of menorrhagia, and decrease of levels of some reproductive hormones are closely associated with HF-EMF (25 approximately 30 MHz)."
03/01/2004 - "Physicians should be made aware of the beneficial health effects of the LNG-IUS, particularly in premenopausal women with menorrhagia and for endometrial protection during hormone replacement."

10/01/2009 - "Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age."
12/01/1980 - "In women with menorrhagia of unknown cause, the efficacy of the drug danazol in reducing heavy menstrual blood loss was investigated making objective measurements of menstrual blood loss. "
01/01/1979 - "Preliminary results on clinical and endocrine studies in the treatment of menorrhagia with danazol."
10/01/2009 - "Vaginal danazol resulted in effective medical treatment in young women with menorrhagia, and, because of a lack of significant adverse effects, it may be proposed as an alternative treatment."
10/01/2009 - "To evaluate the clinical efficacy and patient satisfaction of danazol delivered vaginally as treatment for young women with menorrhagia. "

01/01/2015 - "She had used norethisterone to postpone her menstruation and presented to our institution with severe menorrhagia. "
04/01/2008 - "The regimen of TA 3 g daily during menstrual days 1-5 is a more effective and tolerable treatment than luteal phase norethisterone for patients with ovulatory menorrhagia."
05/01/1995 - "Norethisterone at this dose is not effective therapy for ovulatory menorrhagia."
11/01/2010 - "Continuous high-dose (10 to 20 mg/day) continuous norethisterone to treat menorrhagia in adolescents and young women with bleeding disorders is inadvisable. "
11/01/1993 - "Our purpose was to compare the efficacy of the recommended dose of danazol, a reduced-dose danazol regimen, and norethindrone in the treatment of objectively proven menorrhagia. "

08/01/1996 - "New data have emerged on the frequency of the pathologic causes for menorrhagia and the potential to use new therapies such as gonadotropin-releasing hormone analogues. "
06/16/1992 - "Gonadotropin releasing hormone agonist treatment for severe menorrhagia in patients with contraindications to surgery."
09/01/1984 - "A luteinizing hormone releasing hormone agonist, D-Ser(But)6des Gly10-LHRH ethylamide, was administered intranasally to four women with unexplained ovulatory menorrhagia. "
09/01/1984 - "Use of a superactive luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia."
05/01/1999 - "This pilot study suggests that prompt treatment of perimenopausal menorrhagia with thermal balloon endometrial ablation is as effective and safe as deferred therapy combined with GnRH analog as an endometrium-thinning agent. "

04/01/2009 - "Secondary endpoints included treatment success (defined as a MBL score < 100 after 12 months), hemoglobin levels, and the menorrhagia severity score. "
06/01/2007 - "Menorrhagia and hemoglobin levels."
01/01/2001 - "One of the advantages of the LNG-IUS is that menstrual blood loss will decrease (and therefore hemoglobin levels will increase), which means that the LNG-IUS is one of the most effective reversible long-term treatments of idiopathic menorrhagia. "
01/01/2001 - "One of the advantages of the LNG-IUS is that menstrual blood loss will decrease (and therefore hemoglobin levels will increase), which means that the LNG-IUS is one of the most effective reversible long-term treatments of idiopathic menorrhagia. "
01/01/1998 - "The patient had hypermenorrhea which was appropriately treated resulting in an increase in hemoglobin level but not affecting the Fe deficiency. "

07/01/2013 - "For women who are high anesthetic and surgical risks because of serious underlying comorbidities, nonresectoscopic endometrial ablation can provide minimally invasive, safe, and effective therapy for menorrhagia."
08/17/2009 - "Endometrial ablation is a good treatment for menorrhagia, but in 40% of cases it is followed by further gynaecological surgery. "
10/01/2010 - "In the treatment of menorrhagia, bipolar radiofrequency endometrial ablation system is superior to hydrothermablation. "
05/01/2007 - "Microwave endometrial ablation is a safe and effective global procedure in the management of menorrhagia. "
10/01/2004 - "The bipolar radio-frequency impedance-controlled endometrial ablation system is more effective than balloon ablation in the treatment of menorrhagia."

05/01/2001 - "Both procedures are effective for the treatment of menorrhagia but hysterectomy is associated with better general health and fewer pre-menstrual symptoms. "
07/01/2006 - "Hysterectomy appears to be cost effective, with ICER less than USD50,000, for management of menorrhagia."
02/01/2006 - "With the exception of nonsteroidal antiinflammatory drugs, any treatments effective in the treatment of menorrhagia, including hysterectomy, may be suitable. "
05/01/2008 - "LSH is a safe and effective treatment for menorrhagia and other menstrual disorders when hysterectomy is indicated. "
06/01/2007 - "With regard to the menorrhagia indication, the 5-year follow-up results of a randomized comparative trial of the LNG IUS and hysterectomy have shown equal satisfaction and improvement in health-related quality of life with both treatments. "

07/01/2004 - "To observe the efficacy of Xiaoyan Zhixue Capsule (XYZXC) in treating uterus abnormal menorrhagia caused by intrauterine device (IUD) and to study its mechanism. "
06/01/2013 - "Three-dimensional power Doppler study of endometrial and subendometrial microvascularization in women with intrauterine device-induced menorrhagia."
07/01/2004 - "[Study on clinical efficacy and mechanism of xiaoyan zhixue capsule in treating menorrhagia caused by intrauterine device]."
11/01/2003 - "Both mechanisms of action may have therapeutic value for the treatment of intrauterine device (IUD)-related menorrhagia, which is believed to be caused not only by altered local haemostasis but also-according to a new hypothesis-by decreased vascular uterine resistance. "
08/01/1997 - "Recurrent menorrhagia was observed at 12 months in four women in the intrauterine device group (including two with partial expulsion of the device) and in three women in the resection group. "

01/01/2002 - "For interventional radiological procedures such as uterine artery embolization, further study is recommended before it can be considered as a safe and effective treatment for menorrhagia."
10/01/2006 - "Uterine artery embolization appears to be effective for up to 5 years in reducing bulk symptoms and menorrhagia associated with leiomyomata. "
12/01/2012 - "Laparoscopic or hysteroscopic myomectomy and uterine artery embolization (UAE) have been the most widely studied and all show significantly beneficial effects on menorrhagia and HRQOL, with a low incidence of complications. "
01/01/2009 - "Uterine artery embolization for menorrhagia."
01/01/2007 - "We report a case of life-threatening menorrhagia upon first menses in a 12-year-old girl who was successfully treated with uterine artery embolization after failure of standard gynecologic and medical measures. "

11/01/2015 - "The menstrual volume in 109 patients with menorrhagia was significantly improved after treatment (P<0.001) with a relief rate of 79.8%, 80.7%, and 78.9%, respectively at 3 months, 1 year, and 2 years after HIFU treatment. "
10/01/1995 - " Menorrhagia was reported by 8% of women in the postabortion insertion group and 8.5% of those in the interval insertion group after 1 month and by 5% and 10%, respectively, after 3 months; its incidence was negligible thereafter. "
01/01/2013 - "Treatment failure was defined as persistent or recurrent menorrhagia within one year after treatment or hysterectomy at any time during follow-up. "
12/01/2011 - "After treatment, bipolar radiofrequency endometrial ablation system is more effective at 5 years than hydrothermablation in the treatment of menorrhagia. "
11/01/2003 - "Evaluation of HydroThermAblator and rollerball endometrial ablation for menorrhagia 3 Years after treatment."